Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PKD1L1 antisense RNA 1 (abbreviated as PKD1L1-AS1, also known as C7orf69 or FLJ21075) is a predicted long non-coding RNA transcribed antisense to the PKD1L1 gene. The transcript is uncharacterized, with no robust experimental data confirming its role in cellular or disease processes. It is not established as a protein-coding gene, nor a molecular target for drugs, nor is it implicated in any specific disease mechanisms in the current literature or major molecular databases. Most biomedical resources do not list PKD1L1-AS1 as a receptor, enzyme, transporter, or other classic drug target class. Its annotations in public databases remain sparse, and the molecule is not included in functional target panels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PKD1L1 antisense RNA 1 (PKD1L1-AS1).